Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001813798-25-000004
Filing Date
2025-09-04
Accepted
2025-09-04 16:11:36
Documents
1
Period of Report
2025-09-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1757016692.html 4  
1 FORM 4 wk-form4_1757016692.xml 4 7261
  Complete submission text file 0001813798-25-000004.txt   8804
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300 SAN CARLOS CA 94070
Business Address
Wassil Jim (Reporting) CIK: 0001813798 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39323 | Film No.: 251293524